Results from 236 patients across 28 sites in seven countries presented at LINC 2018 support growing body of evidence for pioneering clinical approach [01-February-2018] LEIPZIG, Germany, Feb. 1, 2018 /PRNewswire/ — An international meta-analysis of clinical experience in patients who received an endovascular arteriovenous fistula (endoAVF) for hemodialysis access was […]
Peripheral/Endo
Boston Scientific’s Ranger DCB and Medtronic’s In.Pact Admiral DCB – Head to Head
This first of it’s kind trial compares two leading DCB technologies. Boston Scientific’s drug-coated balloon goes up against Medtronic’s DCB in first-of-its-kind trial JANUARY 31, 2018 BY SARAH FAULKNER, Drug Delivery Business NEws Top-line results from a head-to-head trial comparing Boston Scientific‘s (NYSE:BSX) Ranger drug-coated balloon and Medtronic‘s (NYSE:MDT) In.Pact Admiral DCB found no […]
Medtronic Closes $28M Purchase of QT Vascular’s Chocolate PTA Balloon Catheter
Medtronic Completes the Purchase of QT Vascular’s Chocolate PTA Balloon Catheter Highlights: – Medtronic completes the purchase of the Company’s non-drug coated Chocolate® PTA balloon catheter – The completion of this purchase validates the value of this internally developed specialty PTA to improve outcomes in patients with peripheral artery disease PLEASANTON, Calif., […]
Medtronic Shows Off IN.PACT Global Critical Limb Ischemia Study Data
IN.PACT Admiral Demonstrates Consistent and Durable Outcomes in New Two-Year Japan Data and IN.PACT Global Critical Limb Ischemia Cohort Analysis Data Presented at LINC 2018 Highlight IN.PACT Admiral as Safe and Effective Treatment Option in PAD DUBLIN and LEIPZIG – January 30, 2018 – Medtronic (NYSE: MDT) today added to its robust […]
Endologix Appoints Greg Morrow as Chief Marketing Officer and Announces Inducement Grants Under NASDAQ Listing Rule 5635(c)(4)
IRVINE, Calif.–(BUSINESS WIRE)– Endologix Inc. (Nasdaq:ELGX), a developer and marketer of innovative treatments for aortic disorders, announced today that it has appointed Greg Morrow as the Company’s Chief Marketing Officer, effective immediately. Mr. Morrow brings to Endologix a wealth of executive marketing experience in medical devices. Most recently, he led the Coronary […]
LimFlow Completes Enrollment In U.S. Feasibility Study and Receives Breakthrough Device Status from FDA for Its Percutaneous Deep Vein Arterialization (pDVA) System
Novel Technology is Designed to Restore Blood Flow to Ischemic Lower Limbs, Which May Resolve Pain, Help Wounds Heal and Avoid Major Amputation PARIS–(BUSINESS WIRE)– LimFlow SA, developer of minimally-invasive technology for the treatment of end-stage critical limb ischemia (CLI), today announced completion of enrollment of the original 10-patient cohort in […]
Medtronic Launches IDE Study to Evaluate the Abre(TM) Venous Self-Expanding Stent System in Patients with Deep Venous Disease
Study to Enroll Subjects at up to 35 Sites Across the U.S. and Europe DUBLIN – January 26, 2018 – Medtronic plc (NYSE: MDT) today announced the initiation of its investigational device exemption (IDE) study for the Abre(TM) venous self-expanding stent system. The ABRE IDE Study will evaluate the safety and […]
TOBA II BTK Trial Enrollment Ahead of Schedule for the Tack Endovascular System® in Below the Knee Disease
WAYNE, Pa.–(BUSINESS WIRE)–Intact Vascular, Inc., a developer of medical devices for minimally invasive peripheral vascular procedures, today announced the Tack Optimized Balloon Angioplasty II Below the Knee (TOBA II BTK) clinical trial surpassed the 100 patient milestone, advancing enrollment well ahead of schedule. The TOBA II BTK is a prospective, […]
FDA Green Lights Surmodics’ Telemark Coronary/Peripheral Support Microcatheter
EDEN PRAIRIE, Minn.–(BUSINESS WIRE)– SurModics (NASDAQ:SRDX), a leading provider of medical device and in vitro diagnostic technologies to the health care industry, announced it has received Food and Drug Administration (FDA) 510(k) clearance for its Telemark™ .014” coronary and peripheral support microcatheter. The Company is making this product available for U.S. distribution in the […]
Cardiovascular Systems Expands Product Portfolio to Further Support Peripheral and Coronary Interventions
ST. PAUL, Minn.–(BUSINESS WIRE)– Cardiovascular Systems, Inc. (CSI) (NASDAQ: CSII), a medical device company developing and commercializing innovative interventional treatment systems for patients with peripheral and coronary artery disease, today announced two new partnerships broadening the company’s product portfolio. CSI is now the exclusive U.S. distributor of OrbusNeich balloon products. Additionally, the […]
